Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
Strang Cancer Prevention Cent
Search grants from Strang Cancer Prevention Cent
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Expanding the accessible genetic architecture of autism by single molecule sequencing
Epidemiology and Development of Alzheimer's Disease (EDAD)
Improving Combined Buprenorphine-Behavioral Treatment
Mechanisms of Immune Modulation by Abscisic Acid
Tuberculosis Elimination and Laboratory
Recently added grants:
CYP1 Inhibition as a New Therapeutic Strategy for Doxorubicin Cardiomyopathy
The role of energy sensor signaling in mitochondrial cardiomyopathy
Xavier RCMI Renewal Application-Overall
A pragmatic, scalable e-health intervention for management of gestational weight gain in low-income mothers
Xavier RCMI Renewal Application-Administrative Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Prevention And Control (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN995015-001
Application #
6994841
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
Strang Cancer Prevention Cent
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2006
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
NIH 2004
N01 CN
Phase II Clinical Trial of Celecoxib /OR Nsaid/ for Prevention of Spor-261995015
/ Strang Cancer Prevention Cent
Comments
Be the first to comment on this grant